复星医药：公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块_老虎社区_美港股上老虎

复星医药：公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块

证券日报2025-12-23

证券日报网讯 12月23日，复星医药在互动平台回答投资者提问时表示，公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块，其中药品、器械及诊断产品的主要市场包括中国、美国、欧洲及新兴市场在内的多个国家和地区。由于业务范围广、产品结构多元，难以以单一指标概括整体市场占有率；但从公司在重点治疗领域的产品渗透度以及持续增长的海外收入占比来看，公司在国内同行业中保持稳固竞争地位，并在国际市场...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2593413090?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-23 22:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2593413090","market":"sh","top_or_hot":-1,"title":"复星医药：公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块","media":"证券日报","content":"<div>\n<p>证券日报网讯 12月23日，复星医药在互动平台回答投资者提问时表示，公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块，其中药品、器械及诊断产品的主要市场包括中国、美国、欧洲及新兴市场在内的多个国家和地区。由于业务范围广、产品结构多元，难以以单一指标概括整体市场占有率；但从公司在重点治疗领域的产品渗透度以及持续增长的海外收入占比来看，公司在国内同行业中保持稳固竞争地位，并在国际市场...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202512233599787764.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药：公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药：公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-23 22:08 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202512233599787764.html><strong>证券日报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券日报网讯 12月23日，复星医药在互动平台回答投资者提问时表示，公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块，其中药品、器械及诊断产品的主要市场包括中国、美国、欧洲及新兴市场在内的多个国家和地区。由于业务范围广、产品结构多元，难以以单一指标概括整体市场占有率；但从公司在重点治疗领域的产品渗透度以及持续增长的海外收入占比来看，公司在国内同行业中保持稳固竞争地位，并在国际市场...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202512233599787764.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09997","symbol_name":"康基医疗","start_time":0,"source_url":"http://finance.eastmoney.com/a/202512233599787764.html","article_id":"2593413090","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2593413090","pubTimestamp":1766498900,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"证券日报网讯12月23日，复星医药在互动平台回答投资者提问时表示，公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块，其中药品、器械及诊断产品的主要市场包括中国、美国、欧洲及新兴市场在内的多个国家和地区。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159760":"医疗健康","159883":"医疗器械","600196":"复星医药","09997":"康基医疗","09996":"沛嘉医疗-B","BK0183":"MSCI概念","BK0188":"融资融券","BK4588":"碎股","BK0012":"证金概念","LABU":"三倍做多标普生物-Direxion","BK0187":"一线龙头","01477":"欧康维视生物-B","BK0028":"国家队","BK0175":"白马股","BK0060":"抗癌","BK4581":"高盛持仓","BK1191":"制药","BK1222":"医疗保健用品","BK1593":"医美概念股","02196":"复星医药","BK4585":"ETF&股票定投概念","BK0196":"行业龙头","BK1100":"医疗保健设备","BK1515":"抗疫概念","XLV":"健康照护类股ETF-SPDR","BK1574":"生物医药B类股","BK0239":"医药制造","XBI":"SPDR S&P Biotech ETF","BK0096":"民营医院","BK1583":"高瓴概念"},"translate_title":"Fosun Pharma: The company's business layout mainly covers three sectors: pharmaceuticals, medical devices and medical diagnosis, and medical and health services","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159760":1.5,"159883":1.5,"600196":1.5,"XLV":1.5,"09996":1.5,"XBI":0.6,"01477":1.5,"LABU":0.6,"09997":1.5,"02196":1.5},"content_text":"证券日报网讯 12月23日，复星医药在互动平台回答投资者提问时表示，公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块，其中药品、器械及诊断产品的主要市场包括中国、美国、欧洲及新兴市场在内的多个国家和地区。由于业务范围广、产品结构多元，难以以单一指标概括整体市场占有率；但从公司在重点治疗领域的产品渗透度以及持续增长的海外收入占比来看，公司在国内同行业中保持稳固竞争地位，并在国际市场不断提升影响力、扩宽布局。（文章来源：证券日报）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}